Skip to main content
  • Telehealth’s Expanding Role in Obesity Care

    Center for Connected Health Policy

    Obesity has long been recognized as one of the most pressing public health issues in the United States, and today its intersection with telehealth is gaining new significance. With the rise of anti-obesity medications (AOMs), particularly GLP-1 receptor agonists such as semaglutide and tirzepatide, more patients are turning to virtual platforms to access treatment, counseling, and long-term management.  GLP-1 receptor agonists work by mimicking the effects of the naturally occurring hormone glucagon-like peptide-1, which helps regulate appetite and blood sugar. By slowing gastric emptying, increasing feelings of fullness, and reducing food intake, these medications have been shown to produce substantial and sustained weight loss in many patients.  Meanwhile, new data from FAIR Health’s Monthly Telehealth Regional Tracker, which was featured in a PR Newswire article in mid-September, revealed that obesity re-entered the top five telehealth diagnostic categories nationally in June 2025, after first appearing in the tracker in February of this year. While mental health remains the dominant reason for telehealth visits across the country, the growing presence of the obesity/overweight diagnosis in the tracker highlights a shift in how patients are using virtual care.

    A recent joint advisory published in the American Journal of Clinical Nutrition by the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society stressed that obesity treatment requires more than pharmacological intervention. While GLP-1s and combination therapies have demonstrated substantial benefits—reducing body weight by 5% to 18% in clinical trials—real-world effectiveness can be undermined by nutritional deficiencies, gastrointestinal side effects, muscle and bone loss, cost barriers, and poor long-term adherence. The advisory emphasizes that evidence-based nutritional and lifestyle strategies must complement pharmacological treatment, which can be supported by telehealth and digital platforms. Without these supports, many patients risk regaining weight once medications are discontinued.

    These recommendations are reinforced by real-world data. A 12-month analysis published in Obesity in 2024 examined over 53,000 patients enrolled in a large-scale telehealth obesity-treatment program.  The analysis reports that participants—most of whom were prescribed GLP-1-based medications—lost an average of 19.4% of body weight at one year. Importantly, side effects declined over time, suggesting that with adequate support, patients can adapt and sustain weight loss in virtual care settings.

    See original resource at :: https://www.cchpca.org/resources/telehealths-expanding-role-in-obesity-care/
    The potential for telehealth to transform obesity care was already being recognized before the explosion of GLP-1 therapies. A 2022 systematic review published in JMIR mHealth and uHealth found that technology-enabled weight management programs—including mobile health apps, digital coaching, and virtual nutrition counseling—were associated with clinically meaningful weight reduction. Many of these interventions achieved similar or better outcomes than traditional in-person programs, especially when paired with behavioral support and tailored nutrition guidance. Taken together, these studies indicate that obesity care is especially well-suited to hybrid or fully virtual delivery—so long as patients receive comprehensive support that extends beyond prescriptions.

    To support the safe and effective use of telehealth in nutrition care, CCHP has identified 13 state dietitian or nutritionist boards, as well as Puerto Rico, that have regulations directly addressing telehealth practice. These can be found in the Professional Requirements Category of our Telehealth Policy Finder.  For example, Iowa’s Board of Dietetics’ administrative code defines a telehealth visit as the provision of dietetic services through secure, HIPAA-compliant two-way audio or video communication (or both) when the provider and patient are in different locations. Licensees must meet the same standard of care as in-person practice, obtain informed consent prior to the first telehealth encounter, and be licensed in Iowa to treat Iowa patients. Regulations also require clinicians to inform patients about risks and limitations, including the possibility of unauthorized access to health information and technology disruptions. This state-level framework highlights the growing recognition of telehealth’s role in dietetic practice while ensuring safeguards for patients.

    For more details on the cited studies and reports, read the full articles and sources linked below:


    REMINDER: Medicare Telehealth Waivers Expire September 30
    Without Congressional Action


    Unless Congress acts, the Medicare telehealth flexibilities that millions of patients and providers have relied upon since March 2020 are scheduled to expire at the end of the month on September 30, 2025. These waivers expanded access to telehealth services during the pandemic and ever since, by loosening restrictions around location, provider eligibility, and the audio-only modality. If the waivers expire, Medicare beneficiaries will face a significant rollback in access to telehealth services unless Congress passes legislation to extend or modify the waiver policies.

    Still, the policy landscape remains in flux, and Congressional negotiations prior to September 30 could shift the outcome. In the past, extensions of the Medicare telehealth waivers have often been tucked into last-minute government spending bills that also averted shutdowns. That pattern may be repeated, as current federal government funding measures—S. 2882 and H.R. 5371—include provisions to extend the waivers, though only temporarily: until October 31, 2025 under S. 2882 and November 21, 2025 under H.R. 5371.   Importantly, for any government funding bill to succeed and be enacted, it must clear both the House and Senate, a significant hurdle, and be signed into law by the President before it can take effect and prevent the September 30 expiration of the Medicare telehealth waivers.  As of now, neither of the bills have advanced past the Senate.

    Earlier this month, Reps. Earl Carter (R-Ga.) and Debbie Dingell (D-Mich.) introduced legislation, HR 5081 – The Telehealth Modernization Act, to extend telehealth flexibilities for Medicare patients through September 30, 2027. Several similar federal bills have previously been introduced in Congress during the 2025 legislative session.  The bills vary, but many would either extend existing telehealth flexibilities or make them permanent. CCHP featured a number of these bills in a July newsletter, and you can continue to track their progress through CCHP’s pending legislation tracker. However, an article in The Hill points out that opponents continue to voice concerns about cost, quality of care, fraud, and potential overuse. According to a report by the Kaiser Family Foundation (KFF), these concerns have become a central part of the debate over how far and how quickly to extend current telehealth flexibilities. Additionally, according to the article previously mentioned, The Hill reported that it reached out to the White House and the Office of Management and Budget for comment on the Administration’s stance regarding reauthorization of Medicare coverage for telehealth services, but no clear position was reported in the article.

    Earlier this summer, CCHP ran a four-part series in our weekly #TelehealthTuesday newsletter exploring what Medicare telehealth policy could look like if the current temporary waivers expire as scheduled. Each article examined the interplay between a potential expiration on September 30 and the proposals outlined in CMS’s proposed 2026 Physician Fee Schedule (PFS), released in July.

    The series highlighted several key areas:

By using this site, you agree to the Privacy Policy and acknowledge the use of cookies to store information, which may be essential to making our site work properly or enhancing user experience.